Bladder Cancer
Bladder Cancer is an international multidisciplinary journal aiming to facilitate progress in understanding the epidemiology, etiology, molecular genetics, pathogenesis, pathobiology and pharmacology of tumors of the bladder and upper urinary tract with the objective of improving diagnosis, treatment and survivorship in patients.
The journal is directed primarily at researchers and clinicians working on these areas, with some content aimed at patients/patient advocates with these conditions. With this objective in mind, the journal publishes original research reports, systematic and regular reviews, short communications, and letters-to-the-editor in basic science, translational research and clinical medicine. The journal is committed to the highest ethical standards and best practices, and prospective authors are encouraged to consult the relevant author instructions and policies on the website at the time of submission as these are updated regularly to reflect changing guidelines.
Submit your manuscript today at https://mc.manuscriptcentral.com/bladdercancer.
Bladder Cancer is an international multidisciplinary journal aiming to facilitate progress in understanding the epidemiology, etiology, molecular genetics, pathogenesis, pathobiology and pharmacology of tumors of the bladder and upper urinary tract with the objective of improving diagnosis, treatment and survivorship in patients. The journal is directed primarily at researchers and clinicians working on these areas, with some content aimed at patients/patient advocates with these conditions. With this objective in mind, the journal publishes original research reports, systematic and regular reviews, short communications, and letters-to-the-editor in basic science, translational research and clinical medicine. The journal is committed to the highest ethical standards and best practices, and prospective authors are encouraged to consult the relevant author instructions and policies on the website at the time of submission as these are updated regularly to reflect changing guidelines.
| Seth P. Lerner, MD | Baylor College of Medicine, USA |
| Dan Theodorescu, MD, PhD | University of Arizona Cancer Center, USA |
| Andrea B. Apolo, MD | National Cancer Institute, USA |
| Jeremy Teoh, MD | The Chinese University of Hong Kong, China |
| Mark S. Soloway, MD | Memorial Healthcare System, USA |
| Piyush K. Agarwal, MD | University of Chicago Medicine, USA |
| Cora N. Sternberg, MD | Weill Cornell Medicine, USA |
| Edward M. Messing, MD | University of Rochester Medical Center, USA |
| Hikmat Al-Ahmadie, MD | Memorial Sloan-Kettering Cancer Center, USA |
| Yves Allory, MD, PhD | University of Paris-Saclay & Institut Curie, France |
| Joaquim Bellmunt, MD, PhD | Beth Israel Deaconess Medical Center, USA |
| Karim Chamie, MD | University of California Los Angeles, USA |
| David J. DeGraff, PhD | Pennsylvania State University College of Medicine, USA |
| Lars Dyrskjøt, PhD | Aarhus University, Denmark |
| Jason A. Efstathiou, MD, DPhil | Massachusetts General Hospital, USA |
| Thomas Flaig, MD | University of Colorado, USA |
| Donna Hansel, MD, PhD | The University of Texas MD Anderson Cancer Center, USA |
| Arndt Hartmann, MD | University Erlangen-Nürnberg, Germany |
| Rebecca Johnson, MPH | Bladder Cancer Advocacy Network (BCAN), USA |
| Anne Kiltie, MA, DM, DSc | University of Aberdeen, UK |
| William Y. Kim, MD | University of North Carolina, USA |
| Yair Lotan, MD | UT Southwestern Medical Center, USA |
| S. Bruce Malkowicz, MD | Hospital of the University of Pennsylvania, USA |
| Surena F. Matin, MD | University of Texas MD Anderson Cancer Center, USA |
| David McConkey, PhD | Johns Hopkins Greenberg Bladder Cancer Institute and Brady Urological Institute, USA |
| Matt Milowsky, MD | University of North Carolina Lineberger Comprehensive Cancer Center, USA |
| Valeria Panebianco, MD | University of Rome La Sapienza, Italy |
| Francisco X. Real, MD, PhD | CNIO (Spanish National Cancer Research Centre), Spain |
| Maria J. Ribal, MD, PhD | Hospital Clinic. University of Barcelona, Spain |
| John P. Sfakianos, MD | Icahn School of Medicine at Mount Sinai, USA |
| Gottfrid Sjödahl, PhD | Lund University, Sweden |
| George Thalmann, MD | University of Bern, Switzerland |
| Bas W.G. van Rhijn, MD, PhD | Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Netherlands |
| Xue-Ru Wu, MD | New York University, USA |
| Alexandre R. Zlotta, MD, PhD | 1. Lunenfeld-Tanenbaum Research Institute 2. Princess Margaret Cancer Centre, Canada |
| Bishoy M. Faltas, MD | Weill Cornell Medicine, New York, USA |
| Weisi Liu, MD | Weill Cornell Medicine, New York, USA |
| Cory Abate-Shen, PhD | Columbia University Medical Center, USA |
| Phillip Abbosh, MD, PhD | Temple University Hospital, USA |
| Marco A. Arap, MD, PhD | The University of São Paulo, Brazil |
| Marko Babjuk, MD | Motol University Hospital, Czech Republic |
| Leslie K. Ballas, MD | Cedars-Sinai Medical Center, USA |
| Rick Bangs, MBA, PMP | Patient Advocate, USA |
| Trinity Bivalacqua, MD, PhD | Johns Hopkins Medicine, USA |
| Peter Black, MD | University of British Columbia, Canada |
| Bernard Bochner, MD | Memorial Sloan-Kettering Cancer Center, USA |
| James Catto, MD, PhD | The University of Sheffield, UK |
| Keith Syson Chan, PhD | Samuel Oschin Comprehensive Cancer Institute, USA |
| Sam S. Chang, MD | Vanderbilt University Medical Center, USA |
| Liang Cheng, MD | Indiana University, USA |
| Bogdan Czerniak, MD, PhD | University of Texas MD Anderson Cancer Center, USA |
| Garrett M. Dancik, PhD | Eastern Connecticut State University, USA |
| Sia Daneshmand, MD | University of Southern California, USA |
| Ian D. Davis, MBBS (Hons), PhD, FRACP, FAChPM | Monash University, Australia |
| Maria De Santis, MD | Charité University Hospital, Germany |
| Colin P.N. Dinney, MD | University of Texas MD Anderson Cancer Center, USA |
| Eliney Ferreira Faria, MD, PhD | Hospital Felicio Rocho, Brazil |
| Mario I. Fernández, MD | Cínica Alemana Universidad del Desarrollo, Chile |
| Georgios Gakis, MD, FEBU | University Hospital of Halle, Germany |
| Matt Galsky, MD | Tisch Cancer Institute, USA |
| Scott Gilbert, MD | H. Lee Moffitt Cancer Center & Research Institute, USA |
| Peter J. Goebell, MD, PhD | Universitätsklinikum Erlangen, Germany |
| John Gore, MD | University of Washington, USA |
| Christian Gratzke, MD | University Hospital Freiburg, Germany |
| Sounak Gupta, MBBS, PhD | Mayo Clinic, USA |
| Noah Hahn, MD | Johns Hopkins University School of Medicine, USA |
| Richard Hautmann, MD | Universität Ulm, Germany |
| Jean Heather Hoffman-Censits, MD | Johns Hopkins University, USA |
| Jer-Tsong Hsieh, PhD | UT Southwestern Medical Center, USA |
| Molly Ingersoll, PhD | Institut Pasteur, France |
| Ashish Kamat, MD | University of Texas MD Anderson Cancer Center, USA |
| Lawrence Karsh, MD, FACS | The Urology Center of Colorado, USA |
| Wassim Kassouf, MD | McGill University Health Center, Canada |
| Lambertus Kiemeney, PhD | Radboud University Medical Center, Netherlands |
| Sunghan Kim, MD PhD | Baylor College of Medicine, USA |
| Deborah W. Knapp, DVM | Purdue University, USA |
| Margaret Knowles, PhD | Leeds Institute of Cancer & Pathology, UK |
| Badrinath Konety, MD | University of Minnesota, USA |
| David Kwiatkowski, MD, PhD | Brigham and Women's Hospital- Harvard Medical School, USA |
| Donald Lamm, MD | University of Arizona, USA |
| Nathan Lawrentschuk, MD, PhD | University of Melbourne, Australia |
| Cheryl Lee, MD | University of Michigan Hospitals, USA |
| Vinata Lokeshwar, PhD | Augusta University Medical College of Georgia, USA |
| Moritz Maas, MD | University Hospitals Tübingen, Germany |
| Nuria Malats, MD | CNIO (Spanish National Cancer Research Centre), Spain |
| Kazumasa Matsumoto, MD | Kitasato University, Japan |
| James McKiernan, MD | Columbia University, USA |
| Reza Mehrazin, MD | The Mount Sinai Hospital, USA |
| Maxwell Meng, MD | University of California San Francisco, USA |
| Timur Mitin, MD, PhD | Oregon Health and Science University, USA |
| Anirban Mitra, MD, PhD | Cedars-Sinai Medical Center, USA |
| Ofer Nativ, MD | Bnai Zion Medical Center, Israel |
| Roman Nawroth, PhD | Technical University of Munich, Germany |
| Matthew Nielsen, MD | School of Medicine, USA |
| Hiroyuki Nishiyama, MD, PhD | University of Tsukuba, Japan |
| Mike O'Donnell, MD | University of Iowa Carver College of Medicine, USA |
| Joan Palou Redorta, MD, PhD | Universitat Autonoma De Barcelona, Spain |
| Dan Petrylak, MD | Yale University, USA |
| Kamal Pohar, MD | Ohio State University, USA |
| Michael Porter, MD | University of Washington, USA |
| Ludmila Prokunina-Olsson, PhD | National Cancer Institute National Institutes Of Health, Bethesda, MD, USA |
| Sarah P. Psutka, MD, MS | University of Washington, USA |
| Nagireddy Putluri, PhD | Baylor College of Medicine, USA |
| François Radvanyi, PhD | Institut Curie, France |
| Derek Raghavan, MD, PhD | Levine Cancer Institute, USA |
| Leonardo O. Reis, MD, MSc, PhD | University of Campinas, Brazil |
| Cyrill Rentsch, MD, PhD | University Hospital Basel, Switzerland |
| Jonathan Rosenberg, MD | Memorial Sloan-Kettering Cancer Center, USA |
| Arthur Sagalowsky, MD | UT Southwestern Medical Center, USA |
| Marta Sanchez-Carbayo, PhD | University of the Basque Country, Spain |
| Bernd Schmitz-Drager, MD, PhD | Friedrich-Alexander University, Germany |
| Mark Schoenberg, MD | The Albert Einstein College of Medicine, USA |
| Shahrokh F. Shariat, MD, PhD | Medical University Vienna, Austria |
| Parminder Singh, MD | Mayo Clinic Arizona, USA |
| Eila C. Skinner, MD | Stanford University, USA |
| Angela B Smith, MD, MS, FACS | UNC-Chapel Hill School of Medicine, USA |
| Steven C. Smith, MD, PhD | Virginia Commonwealth University, USA |
| Gary Steinberg, MD | Rush University Medical Center, USA |
| Arnulf Stenzl, MD | Universitätsklinikum Tübingen, Germany |
| Seth Strope, MD | Baptist MD Anderson Cancer Center, USA |
| Hyun Hwan Sung, MD, PhD | Samsung Medical Center, Korea |
| Robert Svatek, MD, MSCI | UT Health Science Center San Antonio, USA |
| Jennifer M. Taylor, III, MD, MS | Baylor College of Medicine, USA |
| John A. Taylor, MD, MPH | University of Kansas Medical Center, USA |
| Mark Tyson, MD, MPH | Mayo Clinic in Arizona, USA |
| Antonia Vlahou, PhD | Biomedical Research Foundation Academy of Athens, Greece |
| Alfred Witjes, MD, PhD | Radboud University Nijmegen, Netherlands |
| Diane Zipursky Quale, BA, JD | Bladder Cancer Advocacy Network (BCAN), USA |
| Tahlita C.M. Zuiverloon, MD, PhD | Erasmus MC Cancer Institute, Netherlands |
| Michael C. Sachs, PhD | Karolinska Institute, Sweden |
| Jeremy Taylor, PhD | University of Michigan, USA |
| Henning Bahlburg, MD | Marien Hospital Herne, Ruhr University Bochum, Herne, Germany |
| A. Rouf Banday, MSc, PhD | National Cancer Institute, National Institutes of Health, Bethesda, MD, USA |
| Danny Darlington Carbin Joseph, MBBS, MS, MCh, MRCS, FRCS | |
| Jeffrey Damrauer, PhD | University of North Carolina, Chapel Hill, NC, USA |
| Jinhui Gao, BSc (Hons), PhD, FHEA | University College London, London, United Kingdom |
| Benjamin I. Joffe, MD | Columbia University, New York, NY, USA |
| Satoshi Katayama, MD, PhD | |
| Alon Lazarovich, MD, MBA | University of Alberta, Edmonton, Canada |
| Kamil Malshy, MD | University of Rochester Medical Center, Rochester, NY, USA |
| Kent Mouw, MD, PhD | Dana-Farber Cancer Institute/Brigham & Women’s Hospital/Harvard Medical School, Boston, MA, USA |
| Rashid Sayyid, MD, MSc | |
| Marian Severin Wettstein, MD PhD | Northern Ontario School of Medicine and Thunder Bay Regional Health Sciences Centre, Thunder Bay, ON, Canada |